CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis
Crossref DOI link: https://doi.org/10.1038/leu.2014.343
Published Online: 2014-12-08
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Finazzi, M C
Carobbio, A
Cervantes, F
Isola, I M
Vannucchi, A M
Guglielmelli, P
Rambaldi, A
Finazzi, G
Barosi, G
Barbui, T
Text and Data Mining valid from 2014-12-08
Version of Record valid from 2014-12-08
Article History
First Online: 8 December 2014
Competing interests
: The authors declare no conflict of interest